Dicyandiamide – 70 Years of Sustainable Competence and Responsibility
Dicyandiamide – 70 Years of Sustainable Competence and Responsibility

Dicyandiamide

In 1950, SKW Trostberg, as the forerunner to AlzChem, started production of Dicyandimide (DCD). The production plant has been in continuous operation ever since, and constantly improved so that in the current day it respresents one of the most efficient, technically advanced and pollution-free DCD processes in the world. Furthermore, with a capacity of 20,000 to per annum it still represents one of the largest DCD facilities worldwide, and one of the only remaining DCD facilities located outside of China. It fills us with pride that in 2016 we exceeded the total production volume of 1,000,000 tons of DCD.

The big advantage of DCD is that it is extremely reactive but nevertheless non-hazardous, and because of this it is used in a wide variety of applications. The largest application field is as a synthetic component for the production of active pharmaceutical ingredients (API’s), inter alia for the manufacture of the type II anti-diabetes drug Metformin. Another major application field is the hot-curing of epoxy resins for industrial applications, and in recent years Dicyandiamide has a growing importance as a nitrogen stabiliser for agicultural fertilisers. Internally Alzchem also use DCD as a raw material in forward-integrated intermediate products for the production of a diverse range of guanadine salts, guanamines and DCD based condensation products; used in air bags, water treatment, flame retardants, textiles, leather tanning and finishing, and pulp and paper finishing auxiliaries.

Bastian Berger

Bastian Berger

T +49 8621 86-3402

bastian.berger@alzchem.com

News

Trostberg, November 5, 2020 – AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, consistently continues its growth and investment strategy even in the current environment. Due to the continuing high level of market demand, nitrile production will be expanded by up to 50% by the second quarter of 2021. The investment volume amounts to approximately EUR 12 million. The currently available capacities had only been...
read more
A further step towards digitalization for our customers has been successfully implemented on our homepage. If you would like to receive a sample of an AlzChem product for e.g. laboratory trials, simply click on the "ASK FOR A SAMPLE" button. This button is placed in the product finder next to the contact data referring to the product you have chosen. The request can be sent after providing the shipping details. Your sample request will automatically and immediately be forwarded to the...
read more
Over the years AlzChem has built-up a wealth of expertise in micronizing products. We can now draw upon our experience of more than 20 years in this field. We can mix, micronize and homogeneously fill different substances in our in-house milling center at the AlzChem production site Schalchen in Germany. We proudly offer excellent process implementation and support based on many years of expertise, application technology skills and our own research department. AlzChem offers customer...
read more
For many years, AlzChem has been supporting its pharma customers with a wide range of intermediates for medicinal products such as treatment of HIV, cancer, hypertension and diabetes. The current COVID-19 health crisis has again demonstrated the emerging problem of shortages of medicines in Europe and led to consideration of the European Union to regain its health sovereignty by decreasing dependence on non European countries.  Currently, our customers appreciate the reliable...
read more